Medium severity · published May 28, 2024
CVE-2023-37411
IBM Aspera Faspex 5.0.0 through 5.0.6 is vulnerable to cross-site scripting
5.4
CVSS
0.2%
EPSS
No
On KEV
Description
IBM Aspera Faspex 5.0.0 through 5.0.6 is vulnerable to cross-site scripting. This vulnerability allows users to embed arbitrary JavaScript code in the Web UI thus altering the intended functionality potentially leading to credentials disclosure within a trusted session. IBM X-Force ID: 260139.
CVSS vector
CVSS:3.1/AV:N/AC:L/PR:L/UI:R/S:C/C:L/I:L/A:N
Attack vector
Network
Complexity
Low
Privileges
Low
User interaction
Required
Confidentiality
Low
Integrity
Low
Availability
None
Scope
Changed
Exploitation
Is it being used?
Exploit prediction (EPSS)0.2% · higher than 16% of CVEs
Exploited in the wildNo evidence yet
CISA KEVNot listed
Ransomware campaign useNot known
Affected products
Which versions
AF
Aspera Faspex · Ibm
5.0.0 through 5.0.6 · source: NVD
References
NVD
https://nvd.nist.gov/vuln/detail/CVE-2023-37411
CVE.org
https://www.cve.org/CVERecord?id=CVE-2023-37411
Vendor Advisory
https://exchange.xforce.ibmcloud.com/vulnerabilities/260139
Vendor Advisory
https://www.ibm.com/support/pages/node/7154977
More from Aspera Faspex
9.8
CVE-2022-47986
IBM Aspera Faspex code execution
9.8
CVE-2023-37398
IBM Aspera Faspex 5.0.0 through 5.0.10 does not require that users should have strong passwords by default, which makes it easier for attackers to compromise user accounts
9.8
CVE-2023-35907
IBM Aspera Faspex 5.0.0 through 5.0.10 does not require that users should have strong passwords by default, which makes it easier for attackers to compromise user accounts
8.8
CVE-2025-33137
IBM Aspera Faspex 5.0.0 through 5.0.12 could allow an authenticated user to obtain sensitive information or perform unauthorized actions on behalf of another user due to…
8.8
CVE-2025-33136
IBM Aspera Faspex 5.0.0 through 5.0.12 could allow an authenticated user to obtain sensitive information or perform unauthorized actions on behalf of another user due to improper…